Abstract Epithelial-mesenchymal transition (EMT) is a significant process in the invasion and metastasis of cancers including oral squamous cell carcinoma (OSCC), and the cadherin switch has been identified as one of the hallmarks of EMT. The aim of the present study was to evaluate the significance of the cadherin switch in the prognosis of OSCC and generate a model for prognostic predictions. Seventy-six biopsy and/or initial surgical specimens from OSCC patients were immunohistochemically analyzed for the expression of Ecadherin and N-cadherin in either overall OSCC cells in tumor nests or in OSCC cells at the invasive front. Among 76 OSCC cases, overall OSCC cells in tumor nests were negative for the expression of E-cadherin in 10 cases and positive for that of Ncadherin in 53 cases. Among 10 cases negative for the expression of E-cadherin, 4 cases were positive for that of Ncadherin. In OSCC cells at the invasive front, the expression of E-cadherin was negative in 62 cases, while that of N-cadherin was positive in 39 cases. Among 62 cases negative for the expression of E-cadherin, 33 cases were positive for that of N-cadherin. A logistic regression analysis showed that a model using the evaluation of N-cadherin expression in overall OSCC cells in tumor nests with a cut-off point of 70 years old was the best fit model. These results suggest that N-cadherin has significant value in prognostic predictions for OSCC patients.
Introduction
Squamous cell carcinoma (SCC) is the most frequent malignant neoplasia in the oral cavity, with the lateral portion of the tongue being the most commonly affected site [1] . Smoking, drinking alcohol, and poor oral hygiene are regarded as key risk factors for oral squamous cell carcinoma (OSCC) [2] [3] [4] . OSCC has a wellknown characteristic geographical distribution. The incidence of OSCC is higher in South Asian countries, in which the custom of chewing smokeless tobacco is popular, than in North America and European countries, and the epidemiological significance of smokeless tobacco and OSCC has been established [1, 4, 5] . Infections with the human papilloma virus have also been suggested as one of the risk factors for head and neck carcinomas; however, previous studies reported an association with oropharyngeal cancer rather than OSCC [6] [7] [8] . Although several risk factors for OSCC have been established, its prognosis remains unfavorable [7, 9, 10] . Periodical oral examinations are needed in order to improve the prognosis of OSCC.
In histopathological examinations, the development of markers and/or systems to predict prognoses may also contribute to improvements in the prognosis of OSCC. Epithelialmesenchymal transition (EMT) is one of the imperative phenomena explaining the biological mechanisms underlying the infiltration of carcinoma cells into surrounding tissues [11, 12] . Carcinoma cells derived from epithelia are more likely to adhere to one another and form tumor nests, and the invasiveness of assemblages of carcinoma cells is typically milder than that of cellularized carcinoma cells, which are frequently observed in scirrhous carcinomas [13] . In EMT, the expression of the major adhesion molecule of epithelial cells, Ecadherin, is suppressed by the expression of Snail, the transcriptional repressor of E-cadherin, and carcinoma cells comprising tumor nests lose contact and are cellularized [14, 15] . Many in vitro studies have confirmed that transforming growth factor-beta (TGF-β) induces EMT, and treatments with TGF-β not only suppress the expression of E-cadherin, but also induce that of mesenchymal markers [16] [17] [18] . Furthermore, recent studies confirmed that cancer cells with the TGF-β signal induce matrix metalloproteinases and generate cancer stem cells and cancer-associated fibroblasts [11] . Therefore, the detection of EMT or EMT markers, including a decrease in or the loss of E-cadherin expression or the induction of N-cadherin, Snail, and vimentin expression in carcinoma cells, is expected to play a valuable role in prognostic predictions for patients with carcinomas.
EMT has been detected in OSCC specimens, similar to many other carcinoma specimens, and the expression of Ecadherin and N-cadherin has been analyzed [19] [20] [21] . A decrease in or the loss of E-cadherin has been analyzed in detail in previous studies on OSCC or head and neck SCC, and many studies including meta-analyses of published findings have suggested that the strong expression of E-cadherin is a positive prognostic factor, while its weak expression is a negative prognostic factor for OSCC or head and neck SCC [22] [23] [24] [25] [26] [27] [28] . The induction of N-cadherin expression has not been investigated as extensively as the suppression of E-cadherin expression and this may be because its induction is considered to be a more indirect marker of EMT than the suppression of E-cadherin expression. However, previous studies have suggested that the induction of N-cadherin expression is a negative prognostic factor for OSCC patients [29, 30] .
In assessments of E-cadherin expression in histopathological specimens of OSCC cases, it is important that the evaluation is not attenuated by expression in well-differentiated OSCC cells in the core of tumor nests. In order to prevent this attenuation, the expression of E-cadherin has been analyzed in OSCC cells at the invasive front [31, 32] . In contrast, the expression of N-cadherin may be analyzed in overall OSCC cells in tumor nests because the mesenchymal phenotypes of carcinoma cells are one of the definitive markers of the infiltrative nature of carcinoma cells at any portion. We have been investigating the generation of statistical models for prognostic predictions in OSCC patients using several well-known biological markers. Vascular endothelial growth factors (VEGFs) have been identified as one of the essential factors for tumor invasion into surrounding tissues, and we generated a novel logic combination model for prognostic predictions in OSCC patients [33] . We also previously suggested that the expression of podoplanin, a reliable marker of lymphatic endothelial cells, in OSCC cells predicted the prognosis of OSCC patients [34] . In the present study, we analyzed the expression of E-cadherin and N-cadherin in overall OSCC cells in tumor nests and in those at the invasive front. The data obtained were extensively analyzed statistically in order to generate a novel model to predict the prognosis of OSCC patients and estimate an appropriate strategy for histopathological examinations.
Patients and Materials
This study was performed in accordance with the ethical standards of the Declaration of Helsinki, and was approved by the Ethics Committee of Nagasaki University Hospital (approved no. 17022746). This is a retrospective study using previously diagnosed samples and the clinical information. Written informed consent was not used and information regarding this study was disclosed on the website of Nagasaki University Clinical Research Center and assured the right for refusal to use samples and clinical information. Some of the subjects were already passed away and refusal by the proxy of the subject was also permitted.
Seventy-six patients, 51 males and 25 females ranging in age from 31 to 87 years with a median age of 64.9 years, who were admitted to Nagasaki University Dental Hospital between 1983 and 2002 with a histopathological diagnosis of OSCC were analyzed. All patients underwent either biopsy or surgery with or without preoperative treatment. Forty-four patients were treated with a standard program of preoperative irradiation using Linac (total, 30 Gy) and the preoperative continuous subcutaneous administration of peplomycin (5 mg/day; maximum dosage, 100 mg). Four patients were treated with preoperative irradiation only, 13 with the preoperative administration of peplomycin only, and 15 were not treated before surgery. Histopathological analyses diagnosed 63 patients with well-differentiated, 8 with moderately differentiated, and 5 with poorly differentiated OSCC. All patients were followed up at the hospital until 2005; 56 (73.6%) died during and 20 (26.4%) survived the follow-up period.
Histopathological Analyses
Specimens were routinely processed with a 10% buffered formalin fixative, three micrometer-thick sections were made from paraffin-embedded blocks of biopsy or surgical specimens, and sections were stained with hematoxylin and eosin (HE) for histopathological diagnoses. The expression of E-cadherin and N-cadherin was immunohistochemically analyzed with an anti E-cadherin antibody (ab40772, Abcam, Cambridge, UK) and anti N-cadherin antibody (ab98952, Abcam). Sections were incubated with each antibody described above at ×500 dilution with PBS at 4°C overnight and an immunohistochemical analysis was performed on the EnVision + System (Dako, Carpinteria, CA).
The expression of E-cadherin and N-cadherin was evaluated either in overall OSCC cells in tumor nests, which invaded the submucosal region separate from the primary mucosa, or OSCC cells at the invasive front, the deep invasive margins of OSCC [35] . When evaluating overall OSCC cells in tumor nests, we analyzed the expression of E-cadherin and Ncadherin by intensity or the expression area (%). Intensities in OSCC cells were graded as -, ±, +, and ++ under a microscope, and indicated the absence of a positive signal, a weak signal, moderate signal, and strong signal, respectively. Expression at the invasive front was graded as -and +, which indicated the absence of a positive signal and a positive signal, respectively.
Statistical Analyses
The prognostic status was defined as poor for patients that died during the observation period and good for patients that were alive. In a univariate analysis, we used indicator variables for factors with more than two ordered categories in sex, age, and the expression profiles of E-cadherin and N-cadherin. The intensities of E-cadherin or N-cadherin, which were graded as -, ±, +, and ++, were analyzed for each grade. In statistical analyses, areas in OSCC cells were graded as the absence of a signal, <5%, ≥5% to <25%, ≥25% to <50%, ≥50% to <75%, and ≥75%, and were analyzed for each grade. Significant factors from the univariate analysis were further examined in a multivariate analysis using logistic regression models. However, variables for the expression of E-cadherin and Ncadherin were examined in the multivariate analysis irrespective of significance in the univariate analysis. In model selection, we used Akaike's Information Criterion (AIC) [36] . Statistical procedures were performed with Statistical Language R. P-values <0.05 were considered to be significant.
Results
In 76 patients, the expression profiles for E-cadherin and Ncadherin were widely distributed. The detection of E-cadherin expression was slightly more common in relatively large tumor nests (Fig. 1a) ; however, it was also detected in relatively small tumor nests at variable intensities (Fig. 1b, c) . A limited number of patients did not have a positive signal for Ecadherin (Fig. 1d) . In contrast, N-cadherin expression was more likely to be negative in large tumor nests (Fig. 1e) and was more commonly detected in relatively small tumor nests at variable intensities ( Fig. 1f-h) . However, N-cadherin expression was also detected in large tumor nests, which revealed apparent squamous cell differentiation in some patients (Fig. 1g, arrows) . The results of the histopathological analysis also confirmed the presence of OSCC cells in tumor nests expressing Ecadherin and N-cadherin (Fig. 2a, d, arrows) . A positive signal for N-cadherin was a useful marker for identifying small tumor satellites (Fig. 2e, arrows) and individual OSCC cells with EMT (Fig. 2f, arrows) in contrast to the negative reaction for the expression of E-cadherin (Fig. 2b, c) .
The results of the univariate analysis revealed that the prognosis of OSCC patients was not associated with sex, whereas a poor prognosis correlated with age with a cut-off point of 70 years. Neither the intensities nor areas of E-cadherin expression evaluated in overall OSCC cells in tumor nests were associated with the prognosis of OSCC patients. In contrast, the expression of N-cadherin evaluated in overall OSCC cells in tumor nests correlated with the prognosis of OSCC patients. Similar results were obtained for OSCC cells at the invasive front. The expression of N-cadherin, but not that of E-cadherin at the invasive front was associated with the prognosis of OSCC patients (Table 1) . Specification of E-cadherin and Ncadherin expression in overall OSCC cells in tumor nests and OSCC cells at the invasive front was shown in Table 2 .
Variables including age and the expression of N-cadherin and E-cadherin were analyzed in more detail using a multiple logistic regression model. We found that the logistic model with the expression of N-cadherin (±, +, and ++) versus the other (−) evaluated in overall OSCC cells in tumor nests and age (≥70 versus <70) had a smaller AIC than the other multivariate models. (Table 3 ). Figure 3 shows the odds ratio against poor prognosis for OSCC patients evaluated by the model with the smallest AIC.
Discussion
The expression of E-cadherin has been suggested to contribute to prognostic predictions for OSCC patients. However, previous findings have been controversial [37] [38] [39] . EMT is regarded as one of the drivers of the infiltration of carcinoma cells into surrounding tissues by disassembled carcinoma cells at the invasive front. If most OSCC cells reveal scirrhous invasion, EMT may be evaluated in overall OSCC cells in a similar manner to OSCC cells at the invasive front. In contrast, most cases of OSCC exhibit squamous differentiation in the core of tumor nests, and the development of cancer pearls has occasionally been reported in cases of well-differentiated OSCC. In some tumor nests generated by EMT cells, mesenchymalepithelial transition (MET) may occur and is considered to form a core composed of tumor cells with squamous differentiation [40, 41] . OSCC cells in tumor nests with the weak expression of E-cadherin may also completely lose expression at the invasive front [42] . Hence, positive signals in the core of tumor nests may affect the accuracy of evaluations of the EMT-related suppression of E-cadherin expression. This may be one of the reasons for the discrepancy in previous studies that analyzed the relationship between the expression of E-cadherin and prognosis of OSCC patients. The expression of N-cadherin has been reported to contribute to prognostic predictions for OSCC patients [29, 30] . However, previous findings have been controversial [37] , with some studies indicating that the expression of N-cadherin in OSCC was limited more than that of Ecadherin, while the expression of N-cadherin was less applicable than that of E-cadherin to evaluations of the prognosis of OSCC [43, 44] .
In the present study, we immunohistochemically analyzed the expression of E-cadherin and N-cadherin in OSCC specimens and statistically analyzed the data obtained in order to generate a model to predict the prognosis of OSCC patients. We analyzed the intensities and areas of expression of Ecadherin and N-cadherin in overall OSCC cells in tumor nests. In OSCC cells at the invasive front, we detected the presence or absence of OSCC cells with positive signals for E-cadherin or N-cadherin. The results of the univariate analysis showed that the expression of N-cadherin, but not E-cadherin correlated with the prognosis of OSCC patients in every analysis. Significant factors in a univariate analysis are typically only applied to a multivariate analysis in order to generate multiple logistic regression models. In the present study, data on the expression of E-cadherin was used in a multivariate analysis in addition to those for N-cadherin. The multivariate analysis confirmed that the expression of E-cadherin did not contribute to improving the fit of the model using the expression of Ncadherin for prognostic predictions in OSCC patients.
The frequency of the positive expression of E-cadherin was 87% in tumor nests and 18% at the invasive front. On the other hand, the positive frequency of N-cadherin was 70% in tumor nests and 51% at the invasive front. The expression of Ecadherin and N-cadherin were previously shown to be mutually exclusive [12, 45] . However, the results of the present study suggest that changes in these expression profiles were imperfectly reciprocal, and a number of OSCC cells expressed E-cadherin and N-cadherin. These results also indicate that the weak expression of E-cadherin was widely detected in a large number of OSCC cells irrespective of the nature of OSCC cells, including the grade of malignancy, and this may be one of the reasons why the expression of E-cadherin did not Fig. 3 The odds ratio against poor prognosis for OSCC patients with (±, +, ++) or without (−) N-cadherin expression of the selected model contribute to prognostic predictions for OSCC patients in this study. A quantitative evaluation of intensities in an immunohistochemical analysis is generally challenging because they are affected by fixatives and the fixing conditions of specimens. Therefore, the presence of EMT, namely, the weak expression of E-cadherin, was detected less accurately than that of N-cadherin, which was evaluated by a positive signal in the present study. The frequency of the positive expression of N-cadherin was higher in overall OSCC cells in tumor nests than in OSCC cells at the invasive front. The reason for this may be related to the number of OSCC cells expressing N-cadherin. The number of OSCC cells expressing N-cadherin was limited and markedly lower than that expressing E-cadherin. Theoretically, an evaluation at the invasive front is the most accurate approach for detecting the cadherin switch if it is possible to evaluate all OSCC cells in whole specimens. However, we typically perform immunohistochemical examinations using a few representative histopathological sections in a pathological laboratory and this may affect the accuracy of analyzing a limited number of N-cadherin-positive OSCC cells in a small area such as the invasive front. This may also be the reason why we achieved the best fit model using N-cadherin expression in overall OSCC cells in tumor nests rather than in those at the invasive front. However, the AIC scores of a model evaluating the expression of N-cadherin in OSCC cells at the invasive front were not markedly different from those of the best fit model. These results not only confirmed that an evaluation of the expression of N-cadherin is useful for prognostic predictions in OSCC patients, but also suggest that it is possible to evaluate the expression of N-cadherin in overall OSCC cells in tumor nests in a histopathological examination.
In conclusion, we confirmed that the expression of Ncadherin was one of the reliable markers for prognostic predictions in OSCC patients. We suggest that it is possible to evaluate the expression of N-cadherin in overall OSCC cells in tumor nests. We also generated a model to evaluate the prognostic prediction of OSCC using the expression of Ncadherin and age of patients with a cut-off point of 70 years.
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